[Policy Recommendation] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2023 (May 24, 2023)
date : 6/7/2023
Tags: AMR
On May 24, 2023, AMR Alliance Japan (Secretariat: Health and Global Policy Institute) released “Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2023” to promote infectious disease control measures to combat antimicrobial resistance (AMR). The content of the recommendations was as follows.
Promote countermeasures for antimicrobial resistance (AMR) with a One Health approach from perspectives including economic security and serve as a global leader in strengthening preparedness against the threat of infectious disease.
Every year since 2016, Japan’s Basic Policies on Economic and Fiscal Management and Reform have mentioned strengthening efforts to promote AMR control and expanding systems for research, testing, and treatment. Mention of this objective was expanded in 2022 to state, “Japan will also comprehensively examine concrete methods to secure therapeutic drugs for drug-resistant bacteria such as market incentives in measures designed to counter drug resistance, draw conclusions based on these examinations, and then play a leading role in international discussions.” In this manner, Japan has emphasized the importance of AMR control.
As described in the attachment titled, “Promoting Antimicrobial Resistance (AMR) Countermeasures in the Basic Policy on Economic and Fiscal Management and Reform 2023 Recommendation Background,” progress is being made in measures to combat AMR both in Japan and around the world. Looking ahead to the 79th session of the UN General Assembly (UNGA 79) in 2024 and beyond, it will be crucial for Japan to fulfill its commitments to the international community in its capacity as G7 President in 2023 based on the idea that infectious disease control cannot be fully implemented by countries acting alone.
“Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2023” and “Promoting Antimicrobial Resistance (AMR) Countermeasures in the Basic Policy on Economic and Fiscal Management and Reform 2023 Recommendation Background” can be found here.
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Closed] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)
-
2024-10-24
[Event Report] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)